168 related articles for article (PubMed ID: 28428269)
21. New evidence for differential roles of l10 ribosomal proteins from Arabidopsis.
Falcone Ferreyra ML; Casadevall R; Luciani MD; Pezza A; Casati P
Plant Physiol; 2013 Sep; 163(1):378-91. PubMed ID: 23886624
[TBL] [Abstract][Full Text] [Related]
22. [Analysis of mutations of ribosomal protein genes in 21 cases of Diamond-Blackfan anemia].
Chen YM; Ruan M; Zou Y; Guo Y; Wang SC; Chen XJ; Zhang L; Liu TF; Zhu XF
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Dec; 20(6):1414-8. PubMed ID: 23257444
[TBL] [Abstract][Full Text] [Related]
23. New Targets and New Agents in High-Risk Multiple Myeloma.
Nooka AK; Lonial S
Am Soc Clin Oncol Educ Book; 2016; 35():e431-41. PubMed ID: 27249751
[TBL] [Abstract][Full Text] [Related]
24. Ribosomal Protein L10: From Function to Dysfunction.
Pollutri D; Penzo M
Cells; 2020 Nov; 9(11):. PubMed ID: 33227977
[TBL] [Abstract][Full Text] [Related]
25. Diamond-Blackfan anemia: genotype-phenotype correlations in Italian patients with RPL5 and RPL11 mutations.
Quarello P; Garelli E; Carando A; Brusco A; Calabrese R; Dufour C; Longoni D; Misuraca A; Vinti L; Aspesi A; Biondini L; Loreni F; Dianzani I; Ramenghi U
Haematologica; 2010 Feb; 95(2):206-13. PubMed ID: 19773262
[TBL] [Abstract][Full Text] [Related]
26. Resistance to proteasome inhibitors and other targeted therapies in myeloma.
Wallington-Beddoe CT; Sobieraj-Teague M; Kuss BJ; Pitson SM
Br J Haematol; 2018 Jul; 182(1):11-28. PubMed ID: 29676460
[TBL] [Abstract][Full Text] [Related]
27. Ribosomal protein L10 is encoded in the mitochondrial genome of many land plants and green algae.
Mower JP; Bonen L
BMC Evol Biol; 2009 Nov; 9():265. PubMed ID: 19917118
[TBL] [Abstract][Full Text] [Related]
28. Role of ribosomal protein mutations in tumor development (Review).
Goudarzi KM; Lindström MS
Int J Oncol; 2016 Apr; 48(4):1313-24. PubMed ID: 26892688
[TBL] [Abstract][Full Text] [Related]
29. One-lincRNA and five-mRNA based signature for prognosis of multiple myeloma patients undergoing proteasome inhibitors therapy.
Liu Y; Yang N; Peng X; Liu G; Zhong H; Liu L
Biomed Pharmacother; 2019 Oct; 118():109254. PubMed ID: 31357080
[TBL] [Abstract][Full Text] [Related]
30. Bypass of the pre-60S ribosomal quality control as a pathway to oncogenesis.
Sulima SO; Patchett S; Advani VM; De Keersmaecker K; Johnson AW; Dinman JD
Proc Natl Acad Sci U S A; 2014 Apr; 111(15):5640-5. PubMed ID: 24706786
[TBL] [Abstract][Full Text] [Related]
31. The T-cell leukemia related rpl10-R98S mutant traps the 60S export adapter Nmd3 in the ribosomal P site in yeast.
Patchett S; Musalgaonkar S; Malyutin AG; Johnson AW
PLoS Genet; 2017 Jul; 13(7):e1006894. PubMed ID: 28715419
[TBL] [Abstract][Full Text] [Related]
32. Translatome analysis reveals altered serine and glycine metabolism in T-cell acute lymphoblastic leukemia cells.
Kampen KR; Fancello L; Girardi T; Rinaldi G; Planque M; Sulima SO; Loayza-Puch F; Verbelen B; Vereecke S; Verbeeck J; Op de Beeck J; Royaert J; Vermeersch P; Cassiman D; Cools J; Agami R; Fiers M; Fendt SM; De Keersmaecker K
Nat Commun; 2019 Jun; 10(1):2542. PubMed ID: 31186416
[TBL] [Abstract][Full Text] [Related]
33. Integrity of the P-site is probed during maturation of the 60S ribosomal subunit.
Bussiere C; Hashem Y; Arora S; Frank J; Johnson AW
J Cell Biol; 2012 Jun; 197(6):747-59. PubMed ID: 22689654
[TBL] [Abstract][Full Text] [Related]
34. The Tao of myeloma.
Boise LH; Kaufman JL; Bahlis NJ; Lonial S; Lee KP
Blood; 2014 Sep; 124(12):1873-9. PubMed ID: 25097176
[TBL] [Abstract][Full Text] [Related]
35. Proteasome inhibitors for multiple myeloma.
Okazuka K; Ishida T
Jpn J Clin Oncol; 2018 Sep; 48(9):785-793. PubMed ID: 30102324
[TBL] [Abstract][Full Text] [Related]
36. High frequency of ribosomal protein gene deletions in Italian Diamond-Blackfan anemia patients detected by multiplex ligation-dependent probe amplification assay.
Quarello P; Garelli E; Brusco A; Carando A; Mancini C; Pappi P; Vinti L; Svahn J; Dianzani I; Ramenghi U
Haematologica; 2012 Dec; 97(12):1813-7. PubMed ID: 22689679
[TBL] [Abstract][Full Text] [Related]
37. The Human Microbiota in Multiple Myeloma and Proteasome Inhibitors.
Alkharabsheh O; Sidiqi MH; Aljama MA; Gertz MA; Frankel AE
Acta Haematol; 2020; 143(2):118-123. PubMed ID: 31311009
[TBL] [Abstract][Full Text] [Related]
38. Resistance to the Proteasome Inhibitors: Lessons from Multiple Myeloma and Mantle Cell Lymphoma.
Gonzalez-Santamarta M; Quinet G; Reyes-Garau D; Sola B; Roué G; Rodriguez MS
Adv Exp Med Biol; 2020; 1233():153-174. PubMed ID: 32274756
[TBL] [Abstract][Full Text] [Related]
39. RPL29 codes for a non-essential protein of the 60S ribosomal subunit in Saccharomyces cerevisiae and exhibits synthetic lethality with mutations in genes for proteins required for subunit coupling.
DeLabre ML; Kessl J; Karamanou S; Trumpower BL
Biochim Biophys Acta; 2002 Apr; 1574(3):255-61. PubMed ID: 11997090
[TBL] [Abstract][Full Text] [Related]
40. [Proteasome inhibitors in treatment of multiple myeloma].
Kubiczková L; Matějíková J; Sedlaříková L; Kryukov F; Hájek R; Sevčíková S
Klin Onkol; 2013; 26(1):11-8. PubMed ID: 23528167
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
